Allianz Asset Management GmbH - ISIS PHARMACEUTICALS INC DEL ownership

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q1 2019$44,467,000
-39.3%
33,305,000
-51.9%
0.04%
-45.0%
Q4 2018$73,300,000
-15.1%
69,305,000
-15.0%
0.08%
+2.6%
Q3 2018$86,330,000
-2.4%
81,540,000
-9.5%
0.08%
-9.3%
Q2 2018$88,414,000
+61.6%
90,050,000
+65.1%
0.09%
+65.4%
Q1 2018$54,716,000
-14.8%
54,550,000
-9.9%
0.05%
+2.0%
Q4 2017$64,231,000
+3.0%
60,525,000
+3.0%
0.05%
-5.6%
Q3 2017$62,385,000
+25.5%
58,745,000
+25.9%
0.05%
+12.5%
Q2 2017$49,704,000
-17.3%
46,645,000
-25.1%
0.05%
-18.6%
Q1 2017$60,093,000
-22.7%
62,245,000
-17.5%
0.06%
-15.7%
Q4 2016$77,696,000
+21.8%
75,450,000
+10.2%
0.07%
+12.9%
Q3 2016$63,810,00068,450,0000.06%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q3 2023
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 74,881,000$76,559,0001.97%
III Capital Management 15,000,000$15,227,0001.82%
TFG Asset Management GP Ltd 14,055,000$14,321,0001.02%
MACKAY SHIELDS LLC 28,304,000$28,739,0000.21%
RWC Asset Management LLP 6,500,000$6,604,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 7,187,000$7,281,0000.17%
CQS (US), LLC 4,000,000$4,092,0000.13%
FARALLON CAPITAL MANAGEMENT LLC 24,435,000$24,797,0000.12%
D. E. Shaw & Co., Inc. 59,728,000$60,845,0000.06%
BNP Paribas Asset Management Holding S.A. 7,000,000$7,133,0000.03%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders